| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038945 Piperazine pde4 inhibitors and uses thereof |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038936 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/06/2014 | US20140038919 Hepatitis c inhibitors and uses thereof |
| 02/05/2014 | EP2691375A1 Substituted benzimidazoles |
| 02/05/2014 | CN103562191A Nitrogen-containing saturated heterocyclic compound |
| 02/05/2014 | CN103562187A Azole derivative, method for producing same, intermediate compound, and agricultural or horticultural chemical agent and industrial material protecting agent |
| 02/05/2014 | CN103562185A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/05/2014 | CN103554098A One group of 2-chlorine-3-pyridine formyl compounds |
| 02/05/2014 | CN103554091A Quinazoline derivative as well as preparation method and use thereof |
| 02/05/2014 | CN103554090A Terpenoid dihydroquinolone alkaloid compound as well as crystal, preparation method and application thereof as marine anti-fouling agent |
| 02/05/2014 | CN103554088A Benzodiazepine compound and pharmaceutical composition |
| 02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 02/04/2014 | US8642783 Process for preparing chiral compounds |
| 02/04/2014 | US8642774 Compounds |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642585 Indanyloxydihydrobenzofuranylacetic acids |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014018748A1 Lfa-1 inhibitor and polymorph thereof |
| 01/30/2014 | WO2014017844A1 Organic light-emitting compound comprising acridine derivatives, and organic light-emitting device comprising same |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017094A1 Organic electroluminescence element |
| 01/30/2014 | WO2014017045A1 Compound having acridan ring structure, and organic electroluminescent element |
| 01/30/2014 | US20140031561 Crystalline Forms and Processes for Their Preparation |
| 01/30/2014 | US20140031406 Pyrazole compound |
| 01/30/2014 | US20140031388 Akt inactivation by tocopheryl derivatives |
| 01/30/2014 | US20140031387 Lfa-1 inhibitor and methods of preparation and polymorph thereof |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/30/2014 | US20140031373 Pyrimidine derivatives and use thereof as pesticides |
| 01/30/2014 | US20140031371 Poly aromatic sodium channel blockers |
| 01/30/2014 | US20140031360 Bicyclic compounds as pim inhibitors |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031338 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 01/30/2014 | US20140031317 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 01/29/2014 | EP2688884A1 Amorphous form of vilazodone hydrochloride and process for its preparation |
| 01/29/2014 | EP2688403A1 Opioid receptor ligands and methods of using and making same |
| 01/29/2014 | EP2418202B1 (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | EP1790637B1 Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN1849306B Matrix metalloproteinase inhibitors |
| 01/29/2014 | CN103547566A Aminoindane compounds and use thereof in treating pain |
| 01/29/2014 | CN103539790A Rotaxane molecular machine of naphthalimide crown ether and pH meter based on rotaxane molecular machine |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539778A Pyridine-pyrazole heterocyclic dihydrazide derivatives as well as preparation method and application thereof |
| 01/29/2014 | CN103539773A Method for preparing ticagrelor key intermediate |
| 01/29/2014 | CN103539769A Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN102030780B Chiral spiro-phosphate and preparation method and application thereof |
| 01/29/2014 | CN101479252B Methods for the preparation of pyrazole-containing compounds |
| 01/29/2014 | CN101228154B Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 01/28/2014 | US8637550 Heteroaryl diamide compounds useful as MMP-13 inhibitors |
| 01/28/2014 | US8637548 Therapeutic agents useful for treating pain |
| 01/28/2014 | US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
| 01/28/2014 | CA2617213C Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/28/2014 | CA2508170C Pyrazine-based tubulin inhibitors |
| 01/23/2014 | WO2014015105A1 Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
| 01/23/2014 | WO2014015054A1 Beta amino acid derivatives as integrin antagonists |
| 01/23/2014 | WO2014014901A1 Octahydro-cyclopentapyrrolyl antagonists of ccr2 |
| 01/23/2014 | WO2014014874A1 Pyrazole derivatives which inhibit leukotriene production |
| 01/23/2014 | WO2014014698A2 Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
| 01/23/2014 | WO2014014310A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same |
| 01/23/2014 | WO2014014050A1 1-(cycloalkyl-carbonyl)proline derivative |
| 01/23/2014 | WO2014013936A1 Organic electroluminescent element |
| 01/23/2014 | WO2014013721A1 Nitrogen-containing heteroaromatic ring compound and organic electroluminescence element using same |
| 01/23/2014 | WO2014012858A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
| 01/23/2014 | WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof |
| 01/23/2014 | WO2014012505A1 Method for preparing vilazodone and intermediate thereof |
| 01/23/2014 | WO2014012428A1 Oxazolidinone derivative, preparation method thereof and use thereof in medicine |
| 01/23/2014 | WO2014012401A1 Benzo-seven-member heterocyclic derivative and preparation method of benzo-seven-member heterocyclic derivative and medical application of benzo-seven-member heterocyclic derivative |
| 01/23/2014 | US20140024831 4'-demethylepipodophyllotoxin derivative, preparation method and use thereof |
| 01/23/2014 | US20140024829 Process and intermediates for preparing lapatinib |
| 01/23/2014 | US20140024815 Dendrimers with interior and exterior functionalities comprising of azide or alkyne groups for post-functionalization by huisgen click cycloaddition |
| 01/23/2014 | US20140024680 Insecticidal Arylpyrrolines |
| 01/23/2014 | US20140024671 Compositions and methods for inhibiting cytochrome p450 |
| 01/23/2014 | US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97 |
| 01/23/2014 | US20140024658 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 01/23/2014 | US20140024657 Small molecule inhibitors of necroptosis |
| 01/23/2014 | US20140024648 New pyridazinone and pyridone compounds |
| 01/23/2014 | US20140024647 Aromatic heterocyclic derivative having trpv4-inhibiting activity |
| 01/23/2014 | US20140024646 Octahydro-cyclopentapyrrolyl antagonists of ccr2 |
| 01/23/2014 | US20140024640 Benzazepine Derivatives Useful as Vasopressin Antagonists |
| 01/23/2014 | US20140024639 Compounds, Compositions, and Methods for Cancer Therapy |
| 01/23/2014 | US20140024621 Aminopyridine compounds and their uses |
| 01/23/2014 | US20140024619 Benzazepine Derivatives Useful as Vasopressin Antagonists |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/23/2014 | US20140023611 Compounds and methods for inhibiting phosphate transport |
| 01/22/2014 | EP2687518A1 Nitrogen-containing saturated heterocyclic compound |
| 01/22/2014 | EP2687513A1 Drugs for inhibiting aggregation of proteins invoved in diseases linked to protein aggregation and/or neurodegenerative diseases |